Class I
Terminated
Cubicin (daptomycin for injection), 500 mg per vial, Single-dose vial, Rx only. Manuf. for: Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Whitehouse Station, NJ 08889, USA. Manuf. by: Baxter Pharmaceuticals LLC., Bloomington, IN 47403, USA, NDC: 67919-011-01
This recall has been terminated (originally issued November 10, 2021).
- Company
- Merck Sharp & Dohme Corp
- Recall Initiated
- October 19, 2021
- Posted
- November 10, 2021
- Recall Number
- D-0093-2022
- Voluntary / Mandated
- Voluntary: Firm initiated
- Quantity
- 76,163 vials
- Firm Location
- Whitehouse Station, NJ, United States
- Official Source
- View on FDA website ↗
Reason for Recall
Presence of Particulate Matter: Identified as Glass Particles
Distribution
Nationwide within the United States
Lot / Code Info
Lot #: 934778, Exp. Date Jun 2022
More recalls by Merck Sharp & Dohme Corp
Other recent Class I Drug recalls
UDENYCA, pegfilgrastim-cbqv injection, 6 mg/0.6mL Single Dose Prefilled Syringe, Rx only, Manufactu...
Mckesson
· Feb 18, 2026
Green Lumber Natural Fuel For Men capsule, packaged in 2, 4, 10, and 30-count blister packs. GreenLu...
Green Lumber Holdings, Llc
· Feb 11, 2026
Rheumacare capsules, 30 count bottle, Mfg in India by: Virgo UAP Pharma Pvt. Ltd., Ahmedabad, India...
Handelnine Global Llc
· Feb 11, 2026
ClearLife Allergy Nasal Spray, Extra Strength, 0.68 fl. oz. (20 mL) bottles, Distributed by: MediNat...
Medinatura New Mexico, Inc.
· Jan 14, 2026
Famotidine Injection, USP, 20 mg per 2 mL (10 mg per mL), 2 mL vials, Rx only, Fresenius Kabi USA, L...
Fresenius Kabi Usa, Llc
· Dec 3, 2025